Medtronic MiniMed 780G
The Medtronic MiniMed 780G system. [Image from Medtronic]

Medtronic (NYSE:MDT) announced today that reimbursement for its CGMs has been expanded or initiated across a number of countries.

Earlier this month, the Ontario, Canada provincial government announced a comprehensive reimbursement program for continuous glucose monitoring (CGM) for eligible residents who have type 1 diabetes, adding to a similar program for those with type 1 diabetes under 18 years old in Alberta, Canada.

Get the full story at our sister site, Drug Delivery Business News.